psa screening mortality benefit
Prostate Cancer PSA Screening vs No Screening Economics Unveiled
A recent systematic review found that regular PSA screening cuts prostate cancer deaths by 15 percent, saving billions in treatment costs. This finding reshapes how insurers, policymakers, and patients weigh the value of a simple blood test. Medical Disclaimer: This article is for informational purposes only and does not constitute